XML 50 R36.htm IDEA: XBRL DOCUMENT v3.24.1
EMPLOYEE BENEFITS (Tables)
 12 Months Ended
Jan. 31, 2024
Disclosure Text Block Supplement [Abstract]  
Nonvested Restricted Stock Shares Activity [Table Text Block] The following table summarizes legally non-vested restricted stock award activity for fiscal years 2023, 2022, and 2021:
     2023 
     Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
VestingTerm
(in years)		 
                  
  Non-Vested at January 31, 2023   81,264   $2,320    2 
  Granted   113,726    3,945      
  Forfeited   
-
    
-
      
  Vested   32,135    896      
                  
  Non-Vested at January 31, 2024   162,855   $5,369    2 
     2022 
     Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
VestingTerm
(in years)		 
                  
  Non-Vested at January 31, 2022   30,167   $773    1 
  Granted   70,689    2,032      
  Forfeited   450    13      
  Vested   19,142    472      
                  
  Non-Vested at January 31, 2023   81,264   $2,320    2 
     2021 
     Non-Vested
Shares		   Weighted
Average Grant
Date Fair Value
(000’s)		   Weighted
Average Remaining
Vesting Term
(in years)		 
                  
                  
  Non-Vested at January 31, 2021   59,102   $1,398    1 
  Granted   8,409    275      
  Forfeited   
-
    
-
      
  Vested   37,344    900      
                  
  Non-Vested at January 31, 2022   30,167   $773    1 
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] The Company determined there to be no dilutive impact on earnings per shares for January 31, 2023 and 2022. At January 31, 2024, we calculated the diluted weighted average shares as follows (amounts in thousands):
  Weighted average shares - basic   17,482 
  Dilutive effect of RSUs   94 
  Weighted average shares - diluted   17,576